Page last updated: 2024-09-02

deguelin and Melanoma

deguelin has been researched along with Melanoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carpenter, EL; Cassidy, PB; Chagani, S; Ganguli-Indra, G; Indra, AK; Laws, M; Nelson, D	1

Other Studies

1 other study(ies) available for deguelin and Melanoma

Article	Year
Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF Molecular carcinogenesis, 2019, Volume: 58, Issue:9 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Electron Transport Complex I; Humans; MAP Kinase Signaling System; Mechanistic Target of Rapamycin Complex 1; Melanoma; Mitogen-Activated Protein Kinases; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Rotenone; Signal Transduction; Vemurafenib	2019

Article

Year

Mitochondrial complex I inhibitor deguelin induces metabolic reprogramming and sensitizes vemurafenib-resistant BRAF

Molecular carcinogenesis, 2019, Volume: 58, Issue:9

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Resistance, Neoplasm; Electron Transport Complex I; Humans; MAP Kinase Signaling System; Mechanistic Target of Rapamycin Complex 1; Melanoma; Mitogen-Activated Protein Kinases; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Rotenone; Signal Transduction; Vemurafenib

2019